Upgrade to SI Premium - Free Trial

UPDATE: Bristol-Myers Squibb Co. (BMY) PT Raised to $76 at Goldman Sachs

February 7, 2022 5:16 AM
(Updated - February 7, 2022 5:16 AM EST)

Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles